Mabpharm Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '26 Mar 5, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	1,691	1,155	1,897	1,794	4,124	4,330
Market Cap Growth	41.38%	-39.13%	5.75%	-56.50%	-4.76%	-8.70%
Enterprise Value	1,922	1,337	2,080	1,849	3,803	3,619
Last Close Price	0.41	0.28	0.46	0.43	1.00	1.05
PS Ratio	3.64	4.20	19.76	28.38	40.54	-
PB Ratio	15.61	12.20	8.40	3.96	5.58	4.14
P/TBV Ratio	15.61	12.20	8.40	3.96	5.58	4.14
P/FCF Ratio	28.80	-	44.90	-	-	-
P/OCF Ratio	14.97	-	30.00	-	-	-
EV/Sales Ratio	4.14	4.87	21.66	29.24	37.38	-
EV/FCF Ratio	32.73	-	49.23	-	-	-
Debt / Equity Ratio	3.09	3.50	1.38	0.43	0.08	0.05
Debt / FCF Ratio	5.69	-	7.37	-	-	-
Net Debt / Equity Ratio	2.13	2.50	0.53	0.31	-0.06	-0.50
Net Debt / EBITDA Ratio	6.89	-3.37	-0.73	-0.67	0.13	2.62
Net Debt / FCF Ratio	3.94	-7.35	2.85	-0.67	0.10	1.29
Asset Turnover	0.42	0.25	0.09	0.06	0.08	-
Inventory Turnover	0.47	0.37	0.12	0.20	0.39	-
Quick Ratio	0.63	0.62	0.69	0.47	0.53	2.47
Current Ratio	1.07	1.17	1.08	1.07	1.05	2.81
Return on Equity (ROE)	-25.68%	-87.04%	-69.09%	-42.04%	-39.33%	-19.08%
Return on Assets (ROA)	-1.48%	-7.29%	-12.93%	-15.56%	-18.03%	-9.09%
Return on Capital Employed (ROCE)	-3.50%	-17.00%	-28.10%	-31.00%	-44.70%	-19.40%
Earnings Yield	-1.78%	-11.79%	-12.16%	-13.29%	-8.68%	-5.06%
FCF Yield	3.47%	-2.79%	2.23%	-11.47%	-10.36%	-9.45%
Buyback Yield / Dilution	-	-	-	-	-	-8.47%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.